nextgen diagnostics & research tools · nextgen diagnostics & research tools program is...
TRANSCRIPT
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS
Enable clients to provide solutions and capitalize on growth oppor tunities in the precision medicine ecosystem.
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS
2www.frost.com
• Redefine client business value proposition to compete in precision medicine paradigm
• Demonstrate product and service ROI to pathology and research labs
• Address growth oppor tunities in digital solutions and services segments
Program Coverage and Priorities
Program Goals
Program Genesis
Enable clients to provide solutions and capitalize on
growth opportunities in the precision medicine ecosystem
Create a solution set to meet these
changing dynamics?
Integrate these disruptions into
their value chain?
Develop technologies in
a more costmanner?
The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from disruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in
preventative healthcare and adapt new business models to improve profitability and product quality.
INDUSTRY TRANSFORMATION
BENCH
BEDSIDE
RESEARCH USE
CLINICAL USE MOBILE/DIGITAL PREVENTATIVE
INFORMATICS POSTDIAGNOSTICS
HOW WILL DIAGNOSTICS & RESEARCH TOOLS COMPANIES:
NextGen Diagnostics & Research Tools program is centric to capture some of the most transformative pivots in the precision medicine landscape
UDNI
NOITAATMROF
RESEARHO
CH TOOLS COMPAOSTIC
RESEARCH TOOLS COMPANIES:HOW WILL DIAGNOSTICS &
HCNEB
ESUHCRAESER
SS DCITAMROFNI
SCITSONGAIDTSOP
EDISDEB
USELACINILC
the most transformative pivots in the preciNextGen Diagnostics & Research
RPLATIGID/ELIBOM
the most transformative pivots in the preciNextGen Diagnostics & Research
EVITATNEVER
sion medicine landscapethe most transformative pivots in the preciools programTToNextGen Diagnostics & Research
?scimanydgnignahc
esehtteemottesnoitulosaetaerC
sion medicine landscapeis centric to capture some of ools program
et
?niahceulavrieht
otnisnoitpursidesehtetargetnI
sion medicine landscapeis centric to capture some of
manner?tsoceromaniseigolonhce
poleveD
preventative healthcare and adapt new business models to improve profitability and product qualitydisruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
preventative healthcare and adapt new business models to improve profitability and product qualitydisruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
the most transformative pivots in the preci
preventative healthcare and adapt new business models to improve profitability and product qualitydisruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
the most transformative pivots in the preci
preventative healthcare and adapt new business models to improve profitability and product qualitydisruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
sion medicine landscapethe most transformative pivots in the preci
preventative healthcare and adapt new business models to improve profitability and product qualitydisruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
sion medicine landscape
.preventative healthcare and adapt new business models to improve profitability and product qualitydisruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
sion medicine landscape
disruptive trends. It enables companies to stay ahead of the shift from clinical lab focus to patient needs, track investments in The program provides actionable insights to mitigate challenging regulatory impacts and discover growth opportunities from
Growth Opportunities & Companies To- Action
Data Monetisation
Competitive Trends
Digital Transformation
Disruptive Technologies
Innovation Outsourcing
ContractManufacturing
Voice of Customer
Point ofCare
Testing
CompanionDiagnostics
LabAutomation
MolecularDiagnostics
SmartGenomics
New Business Models
Regulatory Trends
Competitive Trends
OutsourcingInnovation
Competitive Trends
Growth Opportunities & Companies To- Action
Customer Voice of
Growth Opportunities & Companies To- Action
Monetisation
Growth Opportunities & Companies To- Action
MonetisationData
New Business ModelsNew Business Models
Digital TransformationDigital Transformation Regulatory TrendsRegulatory Trends
ManufacturingContract
TechnologiesDisruptive
3www.frost.com
Strategies and Business Models
Technologies and Equipment
Solutions and Services
Industry Convergence
Go To Market Insights
KEY PROGRAMME COMPONENTS
Strategies andBusiness Models
EquipmentTechnologies and
Business Models
ServicesSolutions and
Market InsightsConvergenceIndustry
Market InsightsGo To
Why Frost & Sullivan?
OUR STRATEGIC APPROACHA powerful combination of ver tical market depth and Life Sciences exper tise
VERTICAL MARKET DEPTH
HORIZONTAL MARKET BREADTH
Market Coverage fromboth a product and
end-User point of view, throughour Growth Partnership
Service subscriptions andour interactive workshops
and webinarsIn-house
consultingexpertise, offering
the ability to providecustomised supportand guidance from
opportunityidentification to
strategicprioritisation
Leveraging end-usertechnical and regulatory
know-how from othersectors such asDigital Health,
Medical Imaging & Advanced Medical
Technologies
Well establishedand long standing
relationshipswith companies
in the Life Sciencesectors
360 DegreeResearch
Methodologyfocusing on
product, technology,megatrends,
competition, regionaland end-user
trends
STRATEGICINSIGHT
Analysis ofkey topics
driving marketdevelopment
EXECUTIVEBRIEFINGSQuarterly
analysis of trends,opportunities
and competitivelandscape
GROWTH OPPORTUNITIESQuantitative and
qualitative analysisacross sectors
COMPANIES TO ACTION
Firms introducing moral products, solutions and/or
services
BEN
CH T
O B
EDSI
DE
TECH
NO
LOG
IES
& S
ERVI
CES
Lab Service
MolecularDiagnostics
Flow Cytometry
CRISPR/CAS9
NGSTechnologies
Genomics
CompanionDiagnostics
Liquid Biopsy
Point of CareTesting
Single CellGenomics
Quantitative andDigital PCR
Bioinformatics
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS Enable clients to provide solutions and capitalize on
growth opportunities in the precision medicine ecosystem
4www.frost.com
CLINICAL DIAGNOSTICS &RESEARCH TOOLS(2018 Titles)
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS Enable clients to provide solutions and capitalize on
growth opportunities in the precision medicine ecosystem
• 2018 Global Healthcare Industry Outlook
• 2018 Global Life Sciences Industry Outlook
• Global Clinical Lab Services Industry Outlook
• Growth Oppor tunities in Global Lab Instrumentation (Flow Cytometry, Mass spectrometry) Market
• Growth Oppor tunities in Clinical DSS/Informatics Market
• Growth Oppor tunities in DTC Testing Market
• Growth Oppor tunities in Digital PCR and Real Time PCR Market
• Growth Oppor tunities in Liquid Biopsy Market (CTC, ctDNA Technology)
• US POCT Infectious Disease Diagnostics Market- Trends & Emerging Oppor tunities
• EU POCT Infectious Disease Diagnostics Market- Trends & Emerging Oppor tunities
• APAC POCT Infectious Disease Diagnostics Market- Trends & Emerging Oppor tunities
• US Tissue Diagnostics Market-Trends & Emerging Oppor tunities
• Future of Smar t Research Labs-Machine Learning and AI in Genomics
• Spinoff Bump in IVD & Research Tools Market-M&A oppor tunities for MNCs
• GAFA Innovation Mindset- Formula for Excellence to IVD industry?
• US Lab Purchase Trends 2018-Voice of Customer Survey
• Cost Optimization & Impact on Physician Ordering Trends 2018-Voice of Customer Survey
5www.frost.com
CLINICAL DIAGNOSTICS (2017-2016 Titles)
• Growth Oppor tunities in US Prenatal Diagnostics, Forecast to 2021
• Voice of Customer Study- Digital Pathology
• APAC Oncology Diagnostics, Forecasts to 2021
• US Oncology Diagnostics, Forecasts to 2021
• Post conference repor t for Singapore Diagnostics Summit
• Growth Oppor tunities in the Western European Oncology Diagnostics Market, Forecast to 2021
• Growth Oppor tunities in the Western European IVD Industry, Forecast to 2021
• Growth Oppor tunities in the APAC IVD Market, Forecast to 2021
• Growth Oppor tunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021
• US Molecular Diagnostics Market, Forecast to 2021
• European Molecular Diagnostics Market, Forecast to 2022
• APAC Molecular Diagnostics Market, Forecast to 2023
• Western European Molecular Diagnostics Market, 2015 Forecast to 2020
• Global Laboratory Products Purchasing Trends, 2016-2017
• Clinical Laboratories Market in Vietnam, Forecast to 2020
• Analysis of the Indonesian Clinical Laboratories Market
• Analysis of the Australian Clinical Laboratory Market
• US Diabetes Diagnostics Market
• European Diabetes Diagnostics Market
• Trends Impacting Global IVD Market
• US Clinical Laboratory Market
• European Clinical Laboratory Market
• Global Liquid Biopsy Markets (End User Survey)
• US Autoimmune Diagnostics Market
• European Autoimmune Diagnostics Market
• Western Europe Point-of-Care Testing (POCT) Market
• Growth Oppor tunities in the US POCT Market
• APAC POCT Market
• Precision Medicine –Growth Oppor tunities
• US Food Intolerance and Allergy Testing Market
• Price Point Analysis of Laboratory Developed Tests
• APAC Cardiac Biomarkers
• EU Cardiac Biomarkers
• US Cardiac Biomarkers
• Strategic Insight into Global Women’s Reproductive Diagnostics
• Strategic Insight into Global Women’s Urology Diagnostics
• Strategic Insight into Global Women’s Oncology Diagnostics
• Strategic Insight into Global Women’s Cardiology Diagnostics
• Growth Oppor tunities in EU Prenatal Diagnostics, Forecast to 2021
• Global Digital Pathology Market-Companies-2-Action
• Growth Oppor tunities in the Global Digital Pathology Market, Forecast to 2021
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
To be published
To be published
To be published
To be published
To be published
To be published
To be published
Published
Published
Published
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS Enable clients to provide solutions and capitalize on
growth opportunities in the precision medicine ecosystem
6www.frost.com
CLINICAL DIAGNOSTICS (2015-2013 Titles)
• US Blood Transfusion Diagnostics Market
• Analysis of the Western European Immunochemistry Market
• US Self-monitoring Blood Glucose Market
• US Hemostasis Market,
• Global Analysis of Ebola Disease
• Thailand In Vitro Diagnostics Market
• Analysis of the US Immunochemistry Market
• US and European Hantavirus Diagnostics Market
• Long-term Care in Extended Facilities and Nursing Homes in the United States
• Analysis of the Global Infectious Disease Diagnostics Market
• Analysis of the Global In Vitro Diagnostics Market
• US Hematology Diagnostics Market
• Impact of US Healthcare Reform on the In Vitro Diagnostics Market
• Western Europe In Vitro Diagnostics (IVD) Market Data
• Western Europe Urinalysis Market Data
• Western Europe Hemostasis Diagnostics Market Data
• Indonesian Infectious Disease IVD Market
• Western European Companion Diagnostics Market
• Western Europe Hematology Diagnostics Market Data
• Russia In Vitro Diagnostics (IVD) Market Data
• Russia Urinalysis Market Data
• Russia Hemostasis Market Data
• Russia Hematology Diagnostics Market Data
• US In Vitro Diagnostics (IVD) Market Data
• US Urinalysis Market Data
• US Hemostasis Diagnostics Market Data
• US Hematology Diagnostics Market Data
• US Companion Diagnostics Market Trends and Insights
• Global Regulatory Overview For Companion Diagnostics Market
• Survival Strategies for the Global In Vitro Diagnostics Industry
• Analysis of the Global Tissue Diagnostics Market
• Analysis of the Brazilian Market for Reagent Kits in In Vitro Diagnosis
• Tissue Diagnostics - Reimbursement Cuts and Hospital Consolidation to Affect
Purchasing Trends for 2013 and 2014
• In Vitro Diagnostics (IVD) Market Outlook in China
• Global Autoimmune Disease Diagnostics Market
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS Enable clients to provide solutions and capitalize on
growth opportunities in the precision medicine ecosystem
7www.frost.com
NEXTGEN DIAGNOSTICS & RESEARCH TOOLS Enable clients to provide solutions and capitalize on
growth opportunities in the precision medicine ecosystem
RESEARCH TOOLS(2017-2016 Titles)
• 2017 Global Laboratory Purchasing Trends
• US NGS Services market
• Growth Oppor tunities in the US Next-Generation Sequencing Informatics Market
• Growth Oppor tunities in the European NGS Informatics Market, Forecast to 2021
• European Next-generation Sequencing Services Market, Forecast to 2023
• 2016 Global Survey on Clinical Next-Generation Sequencing
• Global Flow Cytometry Market
• European LIMS Market
• US Nucleic Acid and Purification Technologies Market
• 2016 Global Laboratory Purchasing Trends
• US Crispr/CAS9 Market Strategies
RESEARCH TOOLS(2015-2013 Titles)
• Global Flow Cytometry End User Analysis
• Global Survey on Laboratory Information Management Systems
• Global Laboratory Product Purchasing Trends
• US Liquid Handling Market
• Analysis of the US LIMS Market
• Industry Financial Review of the Global Laboratory Research Tools Market
• Western European Liquid Handling Market
• Global Next Generation Sequencing Trends: An End User Perspective
• US Next-generation Sequencing Market
• Global Next-generation Sequencing Market
• Analysis of the Western European Biomarkers Market in Drug Discovery and Development
• Analysis of the Western European Next Generation Sequencing (NGS) Market
• 2014 Projected Global Laboratory Products Budgets
• Global Next Generation Sequencing Informatics Market
• Global Analysis of MicroRNA Tools and Services Market
• Global Mass Spectrometry Market
• Impor tance of Long-term Storage of Clinical Samples
• Cell Culture Purchasing Trends
• U.S. qPCR Reagents Market
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
To be published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
Published
NEXT STEPS
Schedule a Growth Strategy Dialog with our Global Team to discuss yourstrategic growth development, learn from the companies performing best practices and discover growth opportunities impacting your company.
Our Growth Partnership programme integrates everything we do into a continuousand renewable flow of research, vision, strategy, implementation and learning that willhelp your company develop actionable transformational growth strategies that allowyou to survive and thrive in an unpredictable future.
Integrate our Growth Consulting team into your growth pipeline projects, using our proprietarytools and expertise support clients through all five phases of the growth cycle: From developing apipeline of growth opportunities to evaluating and prioritizing those opportunities to formulatingand implementing go-to-market strategies to ongoing monitoring.
Participate at a Growth, Innovation and Leadership Event near you: speak, sponsor, participate... Our GILevents offer a powerful learning environment that integrates collaborative think tanks, networking, visionaryinnovation, and inspirational leadership. Each event is designed to help our clients be fully prepared for afuture of disruption, collapse and transformational growth. Learn more about our Events participation here.
GROWTHSTRATEGY
DIALOG
SURVIVE ANDTHRIVE IN AN
UNPREDICTABLEFUTURE
GAIN ACOMPETITIVE
EDGE ANDIMPROVE YOUR
ROI
GETINVOLVED
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovationthat addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profoundwave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthroughbest practices, changing customer dynamics and emerging economies? Contact Us.
www.frost.com
FOR MORE INFORMATION PLEASE CONTACT [email protected]